| -0.08 / -0.40%|
The 8 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 21.50, with a high estimate of 33.00 and a low estimate of 17.00. The median estimate represents a +7.99% increase from the last price of 19.91.
The current consensus among 9 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.